DC
UPB

Decheng Capital’s Upstream Bio Inc UPB Stock Holding History

Decheng Capital’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5M Sell
2,724,868
-418,210
-13% -$7.52M 3.71% 3
2025
Q4 		$85.3M Sell
3,143,078
-142,215
-4% -$3.54M 11.48% 3
2025
Q3 		$61.8M Hold
3,285,293
– – 10.78% 3
2025
Q2 		$36.1M Hold
3,285,293
– – 9.11% 4
2025
Q1 		$20.1M Hold
3,285,293
– – 5.64% 4
2024
Q4 		$54M Buy
+3,285,293
New +$73.4M 11.58% 3

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM

Decheng Capital's UPB Position: Q1 2026 in Review

Decheng Capital reduced its Upstream Bio Inc (UPB) stake by 13% in Q1 2026, selling an estimated $7.52M and leaving 2,724,868 shares worth $24.5M. The position accounts for 3.71% of the portfolio, ranked #3.

Decheng Capital first reported a position in UPB in Q4 2024 and has held it in 6 quarters since. The position peaked at $85.3M in Q4 2025. 140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Decheng Capital held 2,724,868 shares of Upstream Bio Inc worth $24.5M as of Q1 2026.
  • Decheng Capital sold 418,210 Upstream Bio Inc shares in Q1 2026, an estimated $7.52M.
  • Upstream Bio Inc made up 3.71% of Decheng Capital's portfolio in Q1 2026, its #3 holding.
  • Decheng Capital first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 6 quarters since.
  • Decheng Capital's Upstream Bio Inc position peaked at $85.3M in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Decheng Capital's 13F filing for Q1 2026, filed 13 May 2026.